HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kalidas Shetty Selected Research

alpha-Amylases

6/2010Phenolic compounds, antioxidant activity and in vitro inhibitory potential against key enzymes relevant for hyperglycemia and hypertension of commonly used medicinal plants, herbs and spices in Latin America.
1/2010Phenolic-linked variation in strawberry cultivars for potential dietary management of hyperglycemia and related complications of hypertension.
12/2009Potential of Ginkgo biloba L. leaves in the management of hyperglycemia and hypertension using in vitro models.
8/2009Evaluation of indigenous grains from the Peruvian Andean region for antidiabetes and antihypertension potential using in vitro methods.
4/2009Evaluation of antihyperglycemia and antihypertension potential of native Peruvian fruits using in vitro models.
6/2008Functionality of bioactive compounds in Brazilian strawberry (Fragaria x ananassa Duch.) cultivars: evaluation of hyperglycemia and hypertension potential using in vitro models.
1/2006Potential of cranberry-based herbal synergies for diabetes and hypertension management.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kalidas Shetty Research Topics

Disease

16Hyperglycemia
10/2021 - 01/2004
13Hypertension (High Blood Pressure)
02/2014 - 01/2005
9Type 2 Diabetes Mellitus (MODY)
02/2013 - 01/2005
2Dental Caries (Decay, Dental)
05/2019 - 01/2004
2Chronic Disease (Chronic Diseases)
01/2014 - 01/2004
2Diabetes Complications
01/2005 - 01/2004
1Foodborne Diseases
06/2022
1Colitis
01/2022
1Ulcerative Colitis
01/2022
1Insulin Resistance
01/2021
1Nervous System Diseases (Neurological Disorders)
01/2021
1Non-alcoholic Fatty Liver Disease
10/2020
1Metabolic Syndrome (Dysmetabolic Syndrome X)
10/2020
1Dyslipidemias (Dyslipidemia)
10/2020
1Dysbiosis
10/2020
1Obesity
06/2019
1Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
05/2019
1Parkinson Disease (Parkinson's Disease)
10/2009
1Vascular Diseases (Vascular Disease)
01/2005
1Cardiovascular Diseases (Cardiovascular Disease)
01/2004
1Diabetes Mellitus
01/2004
1Urinary Tract Infections (Urinary Tract Infection)
01/2004
1Neoplasms (Cancer)
01/2004
1Bacterial Infections (Bacterial Infection)
01/2004
1Communicable Diseases (Infectious Diseases)
01/2004
1Peptic Ulcer (Peptic Ulcers)
01/2004
1Arthritis (Polyarthritis)
01/2004

Drug/Important Bio-Agent (IBA)

14AntioxidantsIBA
01/2021 - 01/2004
9Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
11/2013 - 01/2005
8EnzymesIBA
01/2021 - 01/2005
8alpha-Glucosidases (Acid Maltase)IBA
06/2010 - 01/2005
7GlucosidasesIBA
10/2021 - 10/2010
7AmylasesFDA Link
06/2019 - 01/2004
7alpha-AmylasesIBA
06/2010 - 01/2006
5PhytochemicalsIBA
02/2014 - 01/2004
3CarbohydratesIBA
01/2021 - 01/2005
3Glucose (Dextrose)FDA LinkGeneric
01/2021 - 01/2004
31,1-diphenyl-2-picrylhydrazylIBA
02/2013 - 08/2009
3Ethanol (Ethyl Alcohol)IBA
02/2013 - 04/2009
2TeaIBA
01/2022 - 10/2011
2Biological ProductsIBA
01/2021 - 01/2005
2AcidsIBA
05/2019 - 10/2010
2SugarsIBA
10/2010 - 06/2008
2Pancreatic alpha-AmylasesIBA
01/2006 - 01/2005
1Histamine (Histamine Dihydrochloride)FDA Link
06/2022
1Sulfasalazine (Azulfidine)FDA LinkGeneric
01/2022
1Dextran SulfateIBA
01/2022
1Proteins (Proteins, Gene)FDA Link
01/2021
1Free RadicalsIBA
01/2021
1LipidsIBA
01/2021
1Nucleic AcidsIBA
01/2021
1Anthocyanins (Anthocyanin)IBA
10/2020
1Lipase (Acid Lipase)FDA Link
06/2019
1phenolic acidIBA
10/2017
1S-allylcysteine (allyl cysteine)IBA
02/2014
1allicinIBA
02/2014
12,2'- azino- di- (3- ethylbenzothiazoline)- 6- sulfonic acid (ABTS)IBA
11/2013
1HexanesIBA
02/2013
1amarogentinIBA
02/2013
1SolutionsIBA
02/2013
1swerchirinIBA
02/2013
1Complex MixturesIBA
02/2013
1mangiferinIBA
02/2013
1swertiamarinIBA
02/2013
1PowdersIBA
10/2010
1Ellagic AcidIBA
10/2010
1Hydrolyzable TanninsIBA
10/2010
1Levodopa (L Dopa)FDA LinkGeneric
10/2009
1Sweetening Agents (Sweeteners)IBA
06/2008
1Enzyme Inhibitors (Inhibitors, Enzyme)IBA
01/2005
1Starch (Cornstarch)IBA
01/2004
1Proline (L-Proline)FDA Link
01/2004

Therapy/Procedure

1Glycemic Control
01/2021
1Complementary Therapies (Alternative Medicine)
02/2014
1Canes (Cane)
06/2008